The article reviews the evidence for nongenomic transmission of stress reactivity in animals and men. HPA axis physiology and pathophysiology and possibilities of both non-pharmacological (tactile stimulation of infants, psychotherapy) and pharmacological (CRH antagonists, inhibitors of corticosteroid synthesis etc.) treatments of HPA axis dysregulation are discussed.